Clinical Trial Update: Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects [Phase 1]

View source ↗

Summary

A completed Phase 1 pharmacokinetic study of the investigative compound GSK1605786 in healthy Chinese subjects, with Crohn's disease listed among the conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• GSK1605786

Snippet

Sponsor: GlaxoSmithKline | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED